Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: treatment of neurologic disorder (Click to remove) Clinicopathologic Conference, Systemic Immunoglobulin Light-Chain (AL) Amyloidosis NEJM 389:166-175, Case 21-2023, 2023 Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial JAMA 330:512-517, 510, Sims,J.R.,et al, 2023 Clinicopathologic Conference, Systemic Primary Amyloidosis NEJM 384:363-372, Case 3-2021, 2021 Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon Practical Neurology 7:16-23, Christensen,D.B., 2008 Prognosis of patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy Am J Med 104:232-237, Rajkumar,S.V.,et al, 1998 Neuropathies Associated with Paraproteinemia NEJM 338:1601-1607, Ropper,A.H.&Gorson,K.C., 1998 Showing articles 0 to 6 of 6